Viridian Therapeutics Inc Viridian (NASDAQ: VRDN) Declares Pricing of an Underwritten Public Offering Viridian Therapeutics, Inc. (NASDAQ: VRDN) declared the pricing of a public offering of shares of common stock and preferred stock. The firm is expecting to get a profit of nearly $85.0 million.
